Row
N
NVOAI Stock Diagnostic Report
Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
Ozempic manufacturer Novo Nordisk has been downgraded to a sell rating following a sharp decline in its stock price.
View Source Article ↗AI CATALYST SCORE45 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time